New Science Ventures, LLC (NSV) is a leading venture capital firm focused on building companies that leverage breakthrough science to create extraordinary value. NSV invests in companies using science-based innovations to address market needs in Life Sciences (pharmaceuticals, biologics, medical devices, and diagnostics) and Information Technology (e.g., high-performance semiconductors, cellular infrastructure, sensor networks, enterprise software, and storage) sectors.
But many aspects of our strategy are unique to NSV. We:
Focus on fundamental, science-based innovation with strong IP-based protection
Focus on the company-specific context and frequently take contrarian views
Go where the science is. Many of our companies are outside the traditional Tech and Life Science hubs
Build teams that fit the companies’ stage of development, employing “virtual” business models as much as possible
Look for right investment teams and syndicates – willing to lead, follow, or be sole investors
Are patient and continue to support our companies through value inflection points